Charúa GL, Fonseca ME, Guerra MLR, Avendaño EO, García PNJ, Charúa LE

Language: Spanish
References: 39
Page: 22-28
PDF size: 51.93 Kb.

ABSTRACT

Anal fissure is a disease that generally affects to young people, but it can present at any age. Purpose: To show our experience in the treatment of chronic anal fissure with botulinum toxin type A. Material and methods: This is a prospective, experimental and longitudinal study realized in the Coloproctology Unit in the General Hospital of Mexico City and in Medical North of Monterrey, Mexico, between June 2002 and November 2004. Direct variable was healing with 25 units of botulinum toxin. Secondary variables: age, sex, symptomatology, evolution time, localization of fissure, evolution after application of botulinum toxin, complications and time of healing. Results: 35 (67.30%) were female and 17 (32.69%), male; age range, 21 to 64 years, with a medium of 43. At twelve months of toxin, application of 34 (65.38%) patients were asymptomatic, but in four fissure persisted. The other 18 patients were operated on due to persistence of the fissure. In a follow up of 18 months, 30 patients cured (57.69%), 4 improved (7.69%) and 18 (34.61%) were failures; one died by myocardial infarction and there were no recurrences. Conclusions: Botulinum toxin type A is a good alternative in the treatment of chronic anal fissure. Healing or improved with the application of 25 units of botulinum toxin was 65.38%.

REFERENCES

1. Charúa GL. Fisura anal. En: Murguía DD (ed.). Gastroenterología y hepatología práctica. México, D.F.: Intersistemas; 1999, p. 158-62.

2. Metcalf AM. Fisura anal. McGraw-Hill Interamericana Editores, S.A. de C.V. México, D.F. Clin Quir North Am 2002; 82: 1249-55.

3. Jensen SL. Treatment of first episodes of acute anal fissure: prospective randomised study of lignocaine ointment versus hydrocortisone ointment of warm sitz baths plus blan. BMJ 1986; 292: 1167-9.

4. Pascual M, Courtier R, Gil MJ, el al. Estudio ecográfico y manométrico del esfínter anal interno en individuos con fisura anal crónica. Cir Esp 2005; 77: 27-30.

5. Farouk R, Duthie GS, MacGregor AB, et al. Sustained internal sphincter hypertonia in patients with chronic anal fissure. Dis Colon Rectum 1994; 37: 424-9.

6. Wiley M, Day P, Rienger N, et al. Open vs. closed lateral internal sphincterotomy for idiopathic fissure-in-ano: a prospective, randomized, controlled trial. Dis Colon Rectum 2004; 47: 847-52.

7. Nicholls RJ, Dozois RR. Surgery of the colon and rectum. Churchill Livingstone; 1997: 233-44.

8. Kortbeek JB, Langevin JM, Khoo REH, et al. Chronic fissure-in-ano: a randomized study comparing open and subcutaneous lateral internal sphincterotomy. Dis Colon Rectum 1992; 35: 835-7.

9. Hsu T-C, MacKeigan JM. Surgical treatment of chronic anal fissure: a retrospective study of 1753 cases. Dis Colon Rectum 1984; 27: 475-8.

10. Watson SJ, Kamm MA, Nicholls RJ, et al. Topical glyceryl trinitrate in the treatment of chronic anal fissure. Br J Surg 1996; 83: 771-5.

11. Lysy J, Israelit-Yatzkan Y, Sestiere-Ittah M, Keret D, Goldin E. Treatment of chronic anal fissure with isosorbide dinitrate: long-term results and dose determination. Dis Colon Rectum 1998; 41: 1406-10.

12. Parellada C. Randomized, prospective trial comparing 0.2 percent isosorbide dinitrate ointment with sphincterotomy in treatment of chronic anal fissure: a two year follow-up. Dis Colon Rectum 2004; 47: 437-43.

13. Gosselink MP, Darby MD, Zimmerman DDE, et al. Treatment of chronic anal fissure by application of L-arginine gel: a phase II study in 15 patients. Dis Colon Rectum 2005; 48: 832-7.

14. Cook AT, Humphreys MS, Mortensen JN. Oral nifedipine reduces resting anal pressure and heals chronic anal fissure. Br J Surg 1999; 86: 1269-73.

15. Carapeti AE, Kamm AM, Phillips KSR. Topical diltiazem and bethanechol decrease anal sphincter pressure and heal anal fissures without side effects. Dis Colon Rectum 2000; 43: 1359-62.

16. Torrabadella L, Salgado G, Burns RW, et al. Manometric study of topical sildenafil (Viagra®) in patients with chronic anal fissure: sildenafil reduces anal resting tone. Dis Colon Rectum 2004; 47: 733-8.

17. Garrido R, Lagos N, Lattes K, Abedrapo M, et al. Gonyautoxin: new treatment for healing acute and chronic anal fissures. Dis Colon Rectum 2005; 48: 335-43.

18. Mínguez M, Melo F, Espí A, et al. Therapeutic effects of different doses of botulinum toxin in chronic anal fissure. Dis Colon Rectum 1999; 42: 1016-21.

19. Wolfgang H, Schimrigk K. Therapy of anal fissure using botulin toxin. Dis Colon Rectum 1994; 37: 1321-4.

20. Speakman CTM, Burnett SDJ, Kamm MA, et al. Sphincter injury after anal dilatation demonstrated by anal endosonography. Br J Surg 1991; 78: 1429-30.

21. Sohn N, Eisenberg MM, Weinstein MA, et al. Precise anorectal sphincter dilatation: its role in the therapy of anal fissures. Dis Colon Rectum 1992; 35: 322.

22. Renzi A, Brusciano L, Pescatori M, et al. Pneumatic balloon dilatation for chronic anal fissure. A prospective, clinical, endosonographic, and manometric study. Dis Colon Rectum 2005; 48: 121-6.

23. Pernikoff BJ, Eisenstat TE, Rubin RJ, et al. Reappraisal of partial lateral internal sphincterotomy. Dis Colon Rectum 1994; 37: 1291-5.

24. Charúa GL, Sánchez MJ, Avendaño EO. Incontinencia fecal secundaria a esfinterotomía lateral interna parcial como parte del tratamiento quirúrgico de la fisura anal crónica. Cir Gen 2006; 28: 170-6.

25. Hyman N. Incontinence after lateral internal sphincterotomy: a prospective study and quality of life assessment. Dis Colon Rectum 2004; 47: 35-8.

26. Nyam DC, Pemberton JH. Long-tem results of lateral sphincterotomy for chronic anal fissure with particular reference to incidence of fecal incontinence. Dis Colon Rectum 1999; 42: 1306-10.

27. Standards task force, American Society of Colon and Rectal Surgeons. Practice parameters for ambulatory anorrectal surgery. Dis Colon Rectum 1991; 34: 285.

28. Loder PB, Kamm MA, Nicholls RJ, Phillips RK. Reversible chemical sphincterotomy by local application of glyceryl trinitrate. Br J Surg 1994; 81: 1386-9.

29. Richard CS, Gregoire R, Plewes EA, et al. Internal sphincterotomy is superior to topical nitroglycerin in the treatment of chronic anal fissure. Results of a randomized, controlled trial by the Canadian Surgical trials group. Dis Colon Rectum 2000; 43: 1049-58.

30. Griffin N, Zimmerman MD, Briel W, et al. Topical L-arginine gel lowers resting anal pressure. Possible treatment for anal fissure. Dis Colon Rectum 2002; 45: 1332-6.

31. Perrotti P, Bove B, Antropili C, et al. Topical nifedipine with lidocaine ointment vs. active control for treatment of chronic anal fissure: results of a prospective, randomized, double-blind study. Dis Colon Rectum 2002; 45: 1468-75.

32. Dorfman G, Levitt M, Platell C. Treatment chronic anal fissure with topical glyceryl trinitrate. Dis Colon Rectum 1999; 42: 1007-10.

33. Friedenberg F, Gollamudi S, Parkman HP. The use of botulinum toxin for the treatment of gastrointestinal motility disorders. Dig Dis Sci 2004; 49: 165-75.

34. Jost WH, Schimirigk K. Use of botulinum toxin in anal fissure (Letter). Dis Colon Rectum 1993; 36: 974.

35. Brisinda G, Maria G, Bentivoglio AR, et al. Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissure. Surgery 2002; 131: 179-84.

36. Maria G, Brisinda G, Bentivoglio AR, et al. Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure. Am J Surg 2000; 179: 46-50.

37. Maria G, Sganga G, Civello IM, Brisinda G. Botulinum neurotoxin and other treatments for fissure-in-ano and pelvic floor disorders. Br J Surg 2002; 89: 950-61.

38. Maria G, Brisinda G, Bentivoglio AR, et al. Botulinum toxin injections in the internal anal sphincter for the treatment of chronic anal fissure: long-term results after two different dose regimens. Ann Surg 1998; 228: 664-9.

39. Gui D, Cassetta E, Anastasio G, et al. Botulinum toxin for chronic anal fissure. Lancet 1994; 344: 1127-8.